Log in or Sign up for Free to view tailored content for your specialty!
Osteoarthritis and Bone Disorders News
Bone size, trabecular disorganization increase with osteophyte formation
Bone size and trabecular disorganization appear to increase with osteophyte formation and joint space narrowing, while volumetric bone mineral density decreases, according to data published in Arthritis Research & Therapy.
FDA approves abaloparatide for men with osteoporosis at high risk for fracture
The FDA has approved abaloparatide, a parathyroid hormone-related peptide analog, to increase bone mineral density among men with osteoporosis at high risk for fracture, according to an industry press release.
Log in or Sign up for Free to view tailored content for your specialty!
Osteoporosis prevalence remains high in patients with rheumatoid arthritis
Osteoporosis remains highly prevalent among patients with rheumatoid arthritis despite advancements in prevention and treatment, according to data published in Scientific Reports.
Online yoga can provide short-term physical function benefits in osteoarthritis
Compared with online education alone, unsupervised online yoga courses can provide short-term benefits to physical function, but not knee pain, in osteoarthritis, according to data published in the Annals of Internal Medicine.
Lorecivivint delays osteoarthritis structural progression in long-term extension study
Repeat injections of the Wnt pathway inhibitor lorecivivint appears to have slowed the decline of medial joint space width in knee osteoarthritis, according to interim results from a long-term extension trial released by Biosplice.
Top-line results: Vibration belt slows bone strength decline among adults with osteopenia
A belt device that mechanically stimulates bones through vibration slowed the decline in bone strength among adults with osteopenia, according to top-line results announced in an industry press release.
Denosumab achieves structural modification in erosive hand osteoarthritis
PHILADELPHIA — Denosumab successfully induces structural modifications patients with active erosive hand osteoarthritis, according to data presented at ACR Convergence 2022.
Bone-safe glucocorticoid dose ‘hard to find’ in rheumatic, musculoskeletal diseases
PHILADELPHIA — A daily glucocorticoid dose higher than 2.5 mg may lead to irreversible bone mineral density loss regardless of intervention with osteoporosis medications, according to data presented at ACR Convergence 2022.
Diet, exercise instruction improve knee osteoarthritis pain, function
Patients with knee osteoarthritis who are overweight or obese saw reduced knee pain following 18 months of diet and exercise instruction delivered in a community space, according to data presented at ACR Convergence 2022.
Nearly one-third of patients with spine disease asymptomatic at CRMO diagnosis
PHILADELPHIA — Nearly half of patients with spine disease reported no back pain at CRMO onset, and one-third were asymptomatic despite active lesions on whole body MRI at diagnosis, according to data presented at ACR Convergence 2022.
-
Headline News
FDA warns of potential liver injury with Veozah for menopausal hot flashes
September 12, 20242 min read -
Headline News
Video games improved mental health during COVID-19 pandemic
September 12, 20242 min read -
Headline NewsSeptember 12, 20240 min read
-
Headline News
FDA warns of potential liver injury with Veozah for menopausal hot flashes
September 12, 20242 min read -
Headline News
Video games improved mental health during COVID-19 pandemic
September 12, 20242 min read -
Headline NewsSeptember 12, 20240 min read